GRCE
Grace Therapeutics, Inc. · Healthcare
Opaleye Management Inc. bought $124K of Grace Therapeutics, Inc.
10% owner
Bought$123,819
$2.05Price
60,490Shares
+2%Stake
What GRCE did for a copier
- $1,000 copied at Tue, Oct 6 open, $2.08
- $947
- S&P 500, same days
- −0.7%
11 of 30 trading days so far, to the Oct 21 close.
Opaleye Management Inc.'s record
63 other buys with 3 months of prices since 2016: on average +20.3% against the S&P 500, and 33 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Oct 1. Filed Mon, Oct 5, 6:46 PM ET, after the close. Returns use the Oct 6 open and the Oct 21 close. Not investment advice.